Abstract

Oral use of lingonberry (Vaccinium vitis idaea L.) as an alternative for the treatment of melasma in adult women

Highlights

  • Melasma is a chronic hyperpigmentation of the skin, characterized by irregular brownish spots distributed in areas exposed to the sun, common in Brazilian women

  • All participants met the following inclusion criteria: presence of facial melasma in women aged between 30 and 55 years, who had not undergone topical or oral depigmentation treatment for at least six months, and agreed to have their photographs published for scientific purposes.Were excluded from the project, women who were pregnant or lactating, and women with active dermatoses in the area to be treated; who, in the 30 days prior to the study, used products based on hydroquinone, vitamin C, azelaic acid, kojic acid, phytic acid, glycolic acid, antiinflammatories and retinoid derivatives

  • The impact of melasma on quality of life was assessed using the MELASQoL (Melasma Quality of Life scale), a Portuguese language version validated by Cestari et al.[15] at the beginning and at the end of the study

Read more

Summary

Introduction

Melasma is a chronic hyperpigmentation of the skin, characterized by irregular brownish spots distributed in areas exposed to the sun, common in Brazilian women. Objective:A double-blind, longitudinal, comparative and monocentric clinical study was conducted comparing the quality of life and the pigmentation intensity of melasma in women before and 60 days after oral use of Lingonberry (Vaccinium vitis idaea L.) extract in association with sunscreen as the only topical treatment. Results: Evaluation of the Melasma Quality of Life Scale indicated a reduction of the discomfort caused by the pathology after the use of the phytotherapic drug in association with the sunscreen, which did not occur in the group that used the sunscreen alone.The analysis of the pigmentation density in the photographs showed a significant reduction in the degree of pigmentation after the use of phytotherapic drug, as well as no alterations in the control group. Melasma is common melanoderma, characterized by macules on areas exposed to UV radiation, with brownish pigmentation of different intensities, mainly affecting adult women (aged 30 to 55 years) of childbearing age.[2]. The name melasma is, more appropriate for the disease.[3]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.